Angiodynamic Gross Profit

Angiodynamic (ANGO) currently reports a gross profit of $170M as of May 2026. That compares with $160M in the prior-year period — up 12.7% year over year. That is below the Healthcare sector average of $65B. Use the charts on this page to explore Angiodynamic's gross profit history and peer comparisons.

Angiodynamic's gross profit increased from $160M to $170M — a 12.7% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Angiodynamic's gross profit of $170M is lower than the Healthcare sector average of $65B. That is roughly 99.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Angiodynamic reported $170M in gross profit as of May 2026. That compares with $160M in the prior-year period — up 12.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $65B. From there, open related valuation or income-statement pages for Angiodynamic, and consider following ANGO for alerts when major investors trade the stock.